| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.028 | 0.6 |